3-C Institute for Social Development
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, 3-C Institute for Social Development sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
3-C Institute for Social Development: 14 sponsored US clinical trials, none currently recruiting.
3-C Institute for Social Development sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Family Dysfunctional, with 1 trials.
Top-decile sponsor footprint
3-C Institute for Social Development ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
14 total, page 1 of 1
A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination
NCT07300930
Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity
NCT06728800
Assist MH Digital Technologies to Support School Mental Health Care
NCT06728683
Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health
NCT06213142
Pilot Test of a Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination
NCT05743712
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
NCT05630729
The Impact Integrated Data System for Quality and Outcomes Tracking of Prevention Programs
NCT03622138
e-Unstuck:Interactive e-Learning Software for Parents to Support Executive Functioning and Behavior Regulation in Children With Autism Spectrum Disorder
NCT02708069
Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse
NCT03084406
Mobile Technology and Online Tools to Improve Asthma Control in Adolescents
NCT02835300
Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability
NCT02816216
Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients
NCT02861157
Mobile Technology and Online Tools to Track Adherence in Chronic Illness Patients
NCT02864641
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
NCT02715557
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Therapeutic Areas
How the 3-C Institute for Social Development early-phase archive is shaped
14 indexed studies, none listed as recruiting (0% open); 12 completed (86%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Family Dysfunctional (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
3-C Institute for Social Development: archived-pipeline peers nationwide
Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
3-C Institute for Social Development sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 archived trials
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
- Aerin Medical · 14 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this 3-C Institute for Social Development page
14 registered trials is a research-attention snapshot, not an endorsement of 3-C Institute for Social Development or any single study.
- None of 3-C Institute for Social Development's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Family Dysfunctional is the condition 3-C Institute for Social Development studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Family Dysfunctional trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
3-C Institute for Social Development pipeline card: 14 registered trials from official public datasets.Report a data error.